Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Lesson from 3rd US Ebola survivor: Good care works

This article was originally published in Scrip

Executive Summary

While it's unclear if a seven-day course of Tekmira's Pharmaceuticals' experimental RNA interference medicine had a meaningful effect in curing Dr Rick Sacra from the Ebola virus, the University of Massachusetts assistant professor of family medicine and community health is convinced the good care he received at an Omaha, Nebraska hospital gave him the advantage patients in West Africa are not getting.






Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts